BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34158290)

  • 1. Risk of dementia in gout and hyperuricaemia: a meta-analysis of cohort studies.
    Pan SY; Cheng RJ; Xia ZJ; Zhang QP; Liu Y
    BMJ Open; 2021 Jun; 11(6):e041680. PubMed ID: 34158290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta-analysis based on latest evidence.
    Wang L; Tan Z; Wang FY; Wu WP; Wu JC
    Brain Behav; 2023 Oct; 13(10):e3207. PubMed ID: 37667521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gout and risk of dementia, Alzheimer's disease or vascular dementia: a meta-epidemiology study.
    Li X; Huang L; Tang Y; Hu X; Wen C
    Front Aging Neurosci; 2023; 15():1051809. PubMed ID: 37181628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important food sources of fructose-containing sugars and incident gout: a systematic review and meta-analysis of prospective cohort studies.
    Ayoub-Charette S; Liu Q; Khan TA; Au-Yeung F; Blanco Mejia S; de Souza RJ; Wolever TM; Leiter LA; Kendall C; Sievenpiper JL
    BMJ Open; 2019 May; 9(5):e024171. PubMed ID: 31061018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is coffee consumption associated with a lower risk of hyperuricaemia or gout? A systematic review and meta-analysis.
    Zhang Y; Yang T; Zeng C; Wei J; Li H; Xiong YL; Yang Y; Ding X; Lei G
    BMJ Open; 2016 Jul; 6(7):e009809. PubMed ID: 27401353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, its treatment, hyperuricaemia and gout.
    Gibson TJ
    Curr Opin Rheumatol; 2013 Mar; 25(2):217-22. PubMed ID: 23370375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of gout and hyperuricaemia in Australia: An updated systematic review.
    Pathmanathan K; Robinson PC; Hill CL; Keen HI
    Semin Arthritis Rheum; 2021 Feb; 51(1):121-128. PubMed ID: 33360648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gout and hyperuricaemia in the USA: prevalence and trends.
    Singh G; Lingala B; Mithal A
    Rheumatology (Oxford); 2019 Dec; 58(12):2177-2180. PubMed ID: 31168609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
    Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
    Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
    Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of the prevalence of gout and hyperuricaemia in Australia.
    Robinson PC; Taylor WJ; Merriman TR
    Intern Med J; 2012 Sep; 42(9):997-1007. PubMed ID: 24020339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study.
    Ting K; Gill TK; Keen H; Tucker GR; Hill CL
    Intern Med J; 2016 May; 46(5):566-73. PubMed ID: 26765205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial.
    Maglio C; Peltonen M; Neovius M; Jacobson P; Jacobsson L; Rudin A; Carlsson LM
    Ann Rheum Dis; 2017 Apr; 76(4):688-693. PubMed ID: 28076240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional relationship between late-onset epilepsy (LOE) and dementia: A systematic review and meta-analysis of cohort studies.
    Tan Z; Wang FY; Wu WP; Yu LZ; Wu JC; Wang L
    Epilepsy Behav; 2024 Apr; 153():109723. PubMed ID: 38490119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are ultrasound features at the first metatarsophalangeal joint associated with clinically-assessed pain and function? A study of people with gout, asymptomatic hyperuricaemia and normouricaemia.
    Stewart S; Dalbeth N; Vandal AC; Allen B; Miranda R; Rome K
    J Foot Ankle Res; 2017; 10():22. PubMed ID: 28539973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Clinical Association Between Gout and Dementia: A Nationwide Population-Based Cohort Study in Korea.
    Kim JH; Yim DH; Choi IA; Lee J; Park H; Eom SY
    Arthritis Care Res (Hoboken); 2023 May; 75(5):1088-1094. PubMed ID: 35604886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gout epidemic in French Polynesia: a modelling study of data from the Ma'i u'u epidemiological survey.
    Pascart T; Wasik KA; Preda C; Chune V; Torterat J; Prud'homme N; Nassih M; Martin A; Le Masson J; Rodière V; Frogier S; Canova G; Pescheux JP; Shan Sei Fan C; Jauffret C; Claeys P; von Baeyer SL; Castel SE; Emde AK; Yerges-Armstrong L; Fox K; Leask M; Vitagliano JJ; Graf S; Norberciak L; Raynal J; Dalbeth N; Merriman T; Bardin T; Oehler E
    Lancet Glob Health; 2024 Apr; 12(4):e685-e696. PubMed ID: 38485432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study.
    Trifirò G; Morabito P; Cavagna L; Ferrajolo C; Pecchioli S; Simonetti M; Bianchini E; Medea G; Cricelli C; Caputi AP; Mazzaglia G
    Ann Rheum Dis; 2013 May; 72(5):694-700. PubMed ID: 22736095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia].
    Glasnović M
    Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.